Oricula: Oricula Therapeutics secures NIH grant to further develop medicine to preserve hearing
Oricula Therapeutics received a grant of $169,398 through the Small Business Innovation Research Program by the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health (NIH).
Read full article »
Oricula is a biotechnology company that develops and commercializes drugs to prevent hearing loss.
Read more